{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:08:34Z","timestamp":1758416914956,"version":"3.44.0"},"reference-count":3,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jns.2020.116812","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T10:59:59Z","timestamp":1585652399000},"page":"116812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u201cInitial deterioration\u201d upon intravenous methyl-prednisolon in myasthenia is multifactorial"],"prefix":"10.1016","volume":"412","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2839-7305","authenticated-orcid":false,"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla A.","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvio A.","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.116812_bb0005","doi-asserted-by":"crossref","first-page":"116740","DOI":"10.1016\/j.jns.2020.116740","article-title":"Initial deterioration and intravenous methylprednisolone therapy in patients with myasthenia gravis","volume":"412","author":"Sugimoto","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2020.116812_bb0010","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/mus.26319","article-title":"Serial stimulated jitter analysis in juvenile myasthenia gravis","volume":"58","author":"Bhatia","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2020.116812_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nmd.2013.07.012","article-title":"Prepubertal anti-Musk positive myasthenia gravis with long remission","volume":"24","author":"Gungor-Tuncer","year":"2014","journal-title":"Neuromuscul. Disord."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20301489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20301489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:51:03Z","timestamp":1758383463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20301489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":3,"alternative-id":["S0022510X20301489"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.116812","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cInitial deterioration\u201d upon intravenous methyl-prednisolon in myasthenia is multifactorial","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.116812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116812"}}